| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 597,023 | 324,406 | 126,924 | 1,214,436 | | Cost of Revenue |
-
|
-
|
-
| (58,187) | | | Gross Profit | 597,023 | 324,406 | 126,924 | 1,272,623 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,092,536 | 1,049,402 | 923,176 | 2,288,858 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
| (79,793) | 79,793 | 578,398 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (502,257) | (645,203) | (876,045) | (1,594,633) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 90,216 | 58,304 | (34,763) | (295,623) | | Earnings Before Interest And Taxes | (421,701) | (586,899) | (910,808) | (397,612) | | Interest Expense | 5,258 | 87 | 1,399 | 8,682 | | Income Before Tax | (426,959) | (586,986) | (912,207) | (406,294) | | Income Tax Expense | 52,551 | 10,885 | 17,731 | 8,883 | | Minority Interest |
-
|
-
|
-
| 1,492,644 | | | | Net Income From Continuing Ops | 955,768 | (597,871) | (929,938) | (415,177) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 955,768 | (597,871) | (929,938) | (415,177) | | Preferred Stock And Other Adjustments | (1,131,951) | 433,587 | 698,364 |
-
| | | Net Income Applicable To Common Shares | ($176,183) | ($164,284) | ($231,574) | ($415,177) |
|
0.52% Nasdaq 
0.04%
Income Statement
